WuXi Biologics
WuXi Biologics - Discovery, Development, Manufacturing - CDMO - CMO. Spun out of WuXi AppTec.
Launch date
Employees
Market cap
AUD8.9b
Enterprise valuation
AUD7.5b (Public information from Sep 2024)
Share price
HKD12.32 2269.HK
Xuancheng Anhui (HQ)
Financials
Estimates*
CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 5.6b | 10.3b | 15.3b | 17.0b | 17.9b | 20.2b | 23.0b |
% growth | 41 % | 83 % | 48 % | 12 % | 5 % | 13 % | 14 % |
EBITDA | 2.1b | 4.3b | 7.0b | 5.7b | 6.0b | 7.0b | 8.0b |
% EBITDA margin | 37 % | 42 % | 46 % | 33 % | 33 % | 35 % | 35 % |
Profit | 1.7b | 3.4b | 4.4b | 3.4b | 3.3b | 4.1b | 4.9b |
% profit margin | 30 % | 33 % | 29 % | 20 % | 19 % | 20 % | 21 % |
EV / revenue | 62.2x | 30.3x | 14.4x | 6.3x | 1.9x | 1.7x | 1.4x |
EV / EBITDA | 169.4x | 72.0x | 31.6x | 18.9x | 5.8x | 4.9x | 3.9x |
R&D budget | 304m | 502m | 683m | 786m | - | - | - |
R&D % of revenue | 5 % | 5 % | 4 % | 5 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Corporate spinout | ||
* | N/A | - | |
N/A | N/A | IPO | |
Total Funding | - |
Recent News about WuXi Biologics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by WuXi Biologics
Editexited
ACQUISITION by Dechra Pharmaceuticals Jul 2024